Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 30.69 | N/A |
| PEG Ratio (TTM) | -1.02 | N/A |
| P/S Ratio (TTM) | 6.32 | N/A |
| P/B Ratio (TTM) | 3.07 | N/A |
| P/FCF Ratio (TTM) | 17.58 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.79% | N/A |
| ROE (TTM) | 10.30% | N/A |
| Net Profit Margin (TTM) | 20.62% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7.85% | -27.74% | N/A |
| Revenue | 4.60% | 73.22% | N/A |
| Net Income | 8.75% | 1.76% | N/A |
| Cash Flow | 0.30% | 250.13% | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.80 | N/A |
| Quick Ratio (TTM) | 3.80 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 2.27 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |